Literature DB >> 6206246

Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro.

E C Borden, D S Groveman, T Nasu, C Reznikoff, G T Bryan.   

Abstract

The antiproliferative effect of interferons against 5 human bladder carcinoma cell lines, RT112, T24, RT4, 647V and HT1197, was determined in vitro. Each of these human bladder carcinoma cell lines except 647V was sensitive to human interferons in liquid media. The antiproliferative effect of interferons was observed only upon continuous exposure, not after 1 hour. Partially purified, naturally produced interferon beta was more inhibitory of cell growth than naturally produced interferon alpha. Interferon alpha 54, 76, 61, 6L and 1 purified to homogeneity were as effective as naturally produced, partially pure interferon alpha. Although interferon beta, produced by recombinant DNA technology and purified to homogeneity, was not equivalent in effectiveness to naturally produced interferon beta, its antiproliferative activity was greater than interferon alpha 54 for 3 of 4 cell lines tested. Antimitotic effects may underlie, at least in part, the potential therapeutic activity of interferons for bladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206246     DOI: 10.1016/s0022-5347(17)49877-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Antiproliferative effect of interferons on human prostate carcinoma cell lines.

Authors:  G Sica; L Fabbroni; L Castagnetta; M Cacciatore; M Pavone-Macaluso
Journal:  Urol Res       Date:  1989

2.  Recombinant bacille Calmette-Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity.

Authors:  Y Luo; X Chen; R Han; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Characterization of a newly established human urinary bladder cancer cell line (BT-1).

Authors:  W Heckl; J Köhler; H Hoehn; J Dämmrich
Journal:  Urol Res       Date:  1988

4.  Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.

Authors:  B P Priosoeryanto; S Tateyama; R Yamaguchi; K Uchida
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

5.  Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.

Authors:  V J Möbus; W Asphal; P G Knapstein; R Kreienberg
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

6.  Impaired interferon-alpha production in whole-blood cultures from bladder cancer patients.

Authors:  J Y Kuo; Y Nishio; H Kanamaru; Y Okada; M Kita; J Imanishi; T Kishida; O Yoshida
Journal:  Urol Res       Date:  1991

7.  Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro.

Authors:  K Pryor; P Stricker; P Russell; D Golovsky; R Penny
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

Review 8.  Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms' tumor and bladder cancer.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1988-02       Impact factor: 1.798

Review 9.  Immunotherapy for bladder cancer.

Authors:  A M Kamat; D L Lamm
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.